Newspaper publication w.r.t Unaudited Financial Results for the quarter and nine months ended 31/12/2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem Ltd has published its unaudited financial results for Q3 FY26 (Dec 2025) and nine months ended Dec 2025 in Financial Express and Jansatta on Feb 14, 2026, as required under SEBI LODR Regulation 47. Q3 revenue stood at Rs 3,194.97 lakhs, up ~33% sequentially from Rs 2,396.11 lakhs but down ~4.6% YoY from Rs 3,053.03 lakhs. Despite sequential revenue improvement, the company reported a net loss after tax of Rs 37.84 lakhs in Q3 FY26, compared to a profit of Rs 41.09 lakhs in Q3 FY25. For 9M FY26, the net loss widened sharply to Rs 458.03 lakhs versus Rs 24.13 lakhs in 9M FY25. EPS was Rs -0.25 for the quarter and Rs -3.05 for the nine-month period, compared to a positive Rs 0.54 for full-year FY25. Results were approved by the Board on Feb 13, 2026.
Widening year-on-year losses and a revenue dip versus last year signal continued profitability pressure for shareholders. The negative EPS and stretched 9-month loss may weigh negatively on the stock in the near term, though sequential revenue recovery offers a mild offset.